Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

Recent Analyst Ratings for $LFST

$LFST Press Releases

$LFST Insider Trading

$LFST Financials

$LFST SEC Filings

$LFST Large Ownership Changes

Chat with this insight

Fastest customizable press release news feed in the world

Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group

LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024

LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Officer Miller Lisa K sold $78,523 worth of shares (10,540 units at $7.45), decreasing direct ownership by 4% to 288,994 units (SEC Form 4)

New insider Miller Lisa K claimed ownership of 299,534 shares (SEC Form 3)

Director Deluca Teresa was granted 35,211 shares, increasing direct ownership by 97% to 71,574 units (SEC Form 4)

Live finance-specific insights

LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024

LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024

LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024

SEC Form 10-Q filed by LifeStance Health Group Inc.

SEC Form 10-Q filed by LifeStance Health Group Inc.

LifeStance Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

This live feed shows all institutional transactions in real time.

11/14/24 9:59:56 AM ET

$LFST

Medical/Nursing Services

Health Care

Get the next $LFST alert in real time by email

SC 13G/A 1 d900850dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

LifeStance Health Group, Inc.

(Name of Issuer)

Common stock, par value $0.01 per share

(Title of Class of Securities)

53228F101

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1	Calculated based on 382,640,096 shares of common stock, par value $0.01 per share outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

1	Calculated based on 382,640,096 shares of common stock, par value $0.01 per share outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

1	Calculated based on 382,640,096 shares of common stock, par value $0.01 per share outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

1	Calculated based on 382,640,096 shares of common stock, par value $0.01 per share outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

1	Calculated based on 382,640,096 shares of common stock, par value $0.01 per share outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

1	Calculated based on 382,640,096 shares of common stock, par value $0.01 per share outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

SCHEDULE 13G

Item 1.

(a)

Name of Issuer

LifeStance Health Group, Inc., Delaware corporation (the “Issuer”)

(b)

Address of Issuer’s Principal Executive Offices

4800 N. Scottsdale Road, Suite 2300, Scottsdale, Arizona 85251

Item 2.

(a)

Name of Person Filing

This Schedule 13G (the “Schedule 13G”) is being filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

•

Silversmith Partners I GP, LLC;

•

Silversmith Partners I GP, L.P.;

•

Jeffrey Crisan;

•

Silversmith Capital Partners I-A, LP;

•

Silversmith Capital Partners I-B, LP; and

•

Silversmith Capital Partners I-C, LP.

Jeffrey Crisan is a Manager of Silversmith Partners I GP, LLC. Silversmith Partners I GP, LLC is the general partner of Silversmith Partners I GP, L.P., which is the general partner of Silversmith Capital Partners I-A, LP, Silversmith Capital Partners I-B, LP and Silversmith Capital Partners I-A, LP (collectively, the “Silversmith Funds”).

The Reporting Persons have entered into a Joint Filing Agreement, dated February 14, 2022, pursuant to which the Reporting Persons have agreed to file this Amendment No. 1 to Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k)(1) promulgated under the Act.

(b)

Address of Principal Business Office or, if none, Residence

The address of the principal business office of each Reporting Person 116 Huntington Avenue, 15th Floor, Boston, MA 02116.

(c)

Citizenship

The citizenship or place of organization of each Reporting Person is set forth on each Reporting Person’s cover page.

(d)

Title of Class of Securities

Common stock, par value $0.01 per share (the “Common Stock”)

(e)

CUSIP Number

53228F101

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

This Item 3 is not applicable.

Item 4.

Ownership

(a)

Amount beneficially owned:

As of the date hereof, Silversmith Capital Partners I-A, LP holds 12,327,585 shares of Common Stock, representing approximately 3.2% of the outstanding shares of Common Stock, Silversmith Capital Partners I-B, LP holds 4,459,231 shares of Common Stock, representing approximately 1.2% of the outstanding shares of Common Stock, and Silversmith Capital Partners I-C, LP holds 1,129,738 shares of Common Stock, representing approximately 0.3% of the outstanding shares of Common Stock.

As a result of the foregoing and the relationships described in Item 2(a) of this Schedule 13G, the Reporting Persons may be deemed to collectively beneficially own an aggregate of 17,916,554 shares of Common Stock, representing approximately 4.7% of the outstanding shares of Common Stock.

The percentage of the outstanding shares of Common Stock held by the Reporting Persons is based on 382,640,096 shares of Common Stock issued and outstanding as of October 30, 2024 as reported on the Issuer’s 10-Q, filed on November 7, 2024.

(b)

Percent of class:

See Item 4(a) hereof.

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

(ii) Shared power to vote or direct the vote:


Silversmith Partners I GP, LLC			17,916,554
Silversmith Partners I GP, L.P.			17,916,554
Silversmith Capital Partners I-A, LP			12,327,585
Silversmith Capital Partners I-B, LP			4,459,231
Silversmith Capital Partners I-C, LP			1,129,738

(iii) Sole power to dispose or to direct the disposition of:

(iv) Shared power to dispose or to direct the disposition of:


Silversmith Partners I GP, LLC			17,916,554
Silversmith Partners I GP, L.P.			17,916,554
Silversmith Capital Partners I-A, LP			12,327,585
Silversmith Capital Partners I-B, LP			4,459,231
Silversmith Capital Partners I-C, LP			1,129,738

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

None.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

This Item 7 is not applicable.

Item 8.

Identification and Classification of Members of the Group

The Silversmith Funds entered into a Stockholders Agreement, dated as of June 9, 2021 with certain other holders (the “Holders”) of shares of Common Stock. Pursuant to the Stockholders Agreement, the Silversmith Funds and the Holders have agreed to, among other things, vote their shares of Common Stock to elect members of the Board of Directors of the Issuer as set forth therein.

Because of the relationship between the Silversmith Funds and the Holders as a result of the Stockholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Act, to beneficially own the shares of Common Stock beneficially owned by the Silversmith Funds and the Holders and/or to constitute a “group” with the Holders. Each Reporting Person and each Silversmith Fund disclaims beneficial ownership of the shares of Common Stock beneficially owned by the Holders, except to the extent of its pecuniary interest therein, if any.

Item 9.

Notice of Dissolution of Group

This Item 9 is not applicable.

Item 10.

Certification

This Item 10 is not applicable.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 14, 2024


Silversmith Partners I GP, LLC

By:		/s/ Jeffrey Crisan
		Name: Jeffrey Crisan Title: Manager

Silversmith Partners I GP, L.P.

By:		/s/ Jeffrey Crisan
		Name: Jeffrey Crisan Title: Manager of Silversmith Partners I GP, LLC, the General Partner of Silversmith Partners I GP, L.P.

By:		/s/ Jeffrey Crisan
		Name: Jeffrey Crisan

Silversmith Capital Partners I-A, LP

By:		/s/ Jeffrey Crisan
		Name: Jeffrey Crisan Title: Manager of Silversmith Partners I GP, LLC, the General Partner of Silversmith Partners I GP, L.P., the General Partner of Silversmith Capital Partners I-A, L.P.

Silversmith Capital Partners I-B, LP

By:		/s/ Jeffrey Crisan
		Name: Jeffrey Crisan Title: Manager of Silversmith Partners I GP, LLC, the General Partner of Silversmith Partners I GP, L.P., the General Partner of Silversmith Capital Partners I-B, L.P.

Silversmith Capital Partners I-C, LP

By:		/s/ Jeffrey Crisan
		Name: Jeffrey Crisan Title: Manager of Silversmith Partners I GP, LLC, the General Partner of Silversmith Partners I GP, L.P., the General Partner of Silversmith Capital Partners I-C, L.P.

Exhibit List

Exhibit A – Joint Filing Agreement, dated February 14, 2022, incorporated by reference to Exhibit A filed with the Schedule 13G filed by the Reporting Person on February 14, 2022.

Get the next $LFST alert in real time by email

Date	Price Target	Rating	Analyst
1/3/2024	$7.00	Underweight	Barclays
5/15/2023	$8.00 → $9.00	Outperform → Market Perform	TD Cowen
1/6/2023	$8.00	Equal-Weight → Overweight	Morgan Stanley
11/7/2022	$7.25	Buy	Jefferies
3/17/2022	$19.00 → $10.00	Buy → Neutral	UBS
12/17/2021	$15.00 → $10.00	Equal-Weight	Morgan Stanley
11/9/2021	$24.00 → $12.00	Overweight → Neutral	JP Morgan
9/10/2021	$18.00	Outperform	Cowen & Co.

Names of Reporting Persons

Silversmith Partners I GP, LLC

Check the Appropriate Box if a Member of a Group (See Instructions)

(a) ☐ (b) ☐

SEC Use Only

Citizenship or Place of Organization

Delaware